XOMA Corp
NASDAQ:XOMA
XOMA Corp
NASDAQ:XOMA
Price:
25.44 USD
-1.47%
Market Closed
Updated:
May 3, 2024
XOMA Corp
Revenue
|
XOMA Corp
Revenue Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
XOMA Corp
NASDAQ:XOMA
|
Revenue
$4.8m
|
CAGR 3-Years
-45%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-18%
|
|
|
Abbvie Inc
NYSE:ABBV
|
Revenue
$54.3B
|
CAGR 3-Years
6%
|
CAGR 5-Years
11%
|
CAGR 10-Years
11%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Revenue
$27.5B
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
7%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Revenue
$28.2B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
4%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Revenue
$9.9B
|
CAGR 3-Years
17%
|
CAGR 5-Years
26%
|
CAGR 10-Years
23%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Revenue
$13.1B
|
CAGR 3-Years
16%
|
CAGR 5-Years
14%
|
CAGR 10-Years
20%
|
XOMA Corp
Revenue Breakdown
Breakdown by Geography
XOMA Corp
XOMA Corp
|
Total Revenue:
4.8m
USD
|
|
United States:
3.7m
USD
|
|
Asia Pacific:
1.1m
USD
|
Breakdown by Segments
XOMA Corp
XOMA Corp
Not Available
See Also
What is XOMA Corp's Revenue?
Revenue
4.8m
USD
4.8m
USD
Based on the financial report for Dec 31, 2023, XOMA Corp's Revenue amounts to 4.8m USD.
What is XOMA Corp's Revenue growth rate?
Revenue CAGR 10Y
-18%
-18%
Over the last year, the Revenue growth was -21%. The average annual Revenue growth rates for XOMA Corp have been -45% over the past three years , -2% over the past five years , and -18% over the past ten years .
You don't have any saved screeners yet
